Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

ON-AIR 🟢 - Poo-tane Gas 50 min · 23 Sep 2026 · The Morning Rumble

Lemon LIVE at 5: Trump's Attack on the Media is an Attack on Democracy 57 min · 23 Sep 2026 · The Don Lemon Show

Iran's President Addresses the UN General Assembly 3 min · 23 Sep 2026 · Fox News Hourly Update

NPR News: 09-23-2026 6PM EDT 5 min · 23 Sep 2026 · NPR News Now

Matheson on Guerrero Jr.'s contract comments, his season performance and the optics of the statement 10 min · 23 Sep 2026 · OverDrive

H3 Tim Grunhard 39 min · 23 Sep 2026 · The Program

Report any issue

Source

Recorded30 Oct 2025

Publisherc.answersincme.com ↗

Handlerec:10296209

Show notes

Please visit answersincme.com/860/97851223-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in lung cancer discuss the growing importance of immunotherapy in the management of limited-stage small-cell lung cancer (LS-SCLC). Upon completion of this activity, participants should be better able to: Review the clinical impact of immunotherapy-based regimens for the management of small-cell lung cancer (SCLC); and Identify clinical factors that drive treatment decision-making for patients with SCLC.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in